Fetal Macrosomia
14
0
0
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
88.9%
+2.4% vs benchmark
7%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (14)
Dextrose Gel Does Not Prevent Neonatal Hypoglycemia
Investigating the Relationship Between Triglycerides and Fetal Overgrowth in Gestational Diabetes
A Comparative Study of AI Methods for Fetal Diagnostic Accuracy in Ultrasound
Timing of Ambulation and Infant Birth Weight in Gestational Diabetes
Estimation of Fetal Weight by MR Imaging to PREdict Neonatal MACROsomia (PREMACRO Study)
Gut Microbiota, SCFAs and Glucolipid Metabolism in Pregnant Women With Abnormal Fetal Size and Their Newborns
Regulation Of Maternal Fuel Supply And Neonatal Adiposity
Automated Fetal Weight Estimation: A Multicenter Validation Using Fractional Limb Volume
Prediction of Fetal Macrosomia by US
Correlation Between Placental Thickness in the Second and Third Trimester and Fetal Weight
Fetal Front-abdominal Wall Thickness and Perinatal Outcome
Treatment of Impaired Glucose Tolerance in Pregnancy
Fish Oil Supplementation in Women With Gestational Diabetes
DAME: Induction of Labor or Waiting for Suspicion Fetal Macrosomia